The future of glioma treatment: stem cells, nanotechnology and personalized medicine

2012 ◽  
Vol 8 (9) ◽  
pp. 1149-1156 ◽  
Author(s):  
Maryam Rahman ◽  
Brian Hoh ◽  
Nathan Kohler ◽  
Erin M Dunbar ◽  
Gregory JA Murad
2019 ◽  
Vol 8 (1) ◽  
pp. 117 ◽  
Author(s):  
Katherine Brown ◽  
Mahendra Rao ◽  
Heather Brown

Newborn stem cell banking began with the establishment of cord blood banks more than 25 years ago. Over the course of nearly three decades, there has been considerable evolution in the clinical application of stem cells isolated from newborn tissues. The industry now finds itself at an inflection point as personalized medicine and regenerative medicine continue to advance. In this review, we summarize our perspective on newborn stem cell banking in the context of the future potential that stem cells from perinatal tissues are likely to play in nascent applications. Specifically, we describe the relevance of newborn stem cell banking and how the cells stored can be utilized as starting material for the next generation of advanced cellular therapies and personalized medicine.


2016 ◽  
Vol 3 (10) ◽  
pp. 857 ◽  
Author(s):  
Phuc Van Pham

Stem cells represent a new treatment option in medicine and pharmacy. Stem cells have been increasingly used for the treatment of many diseases. In fact, they have spurred a new age of medicine called regenerative medicine. In recent years, regenerative medicine has become a new revolution in disease treatment, especially with the use of stem cell drugs. Stem cell drugs refer to live stem cell based products that used as drugs for particular diseases. Unlike autologous stem cell transplantation, stem cell drugs are “off-the-shelf” products that are ready to be used without requirement of any further manipulation. This review aims to summarize some of the approved stem cell drugs, and discuss the revolution of regenerative medicine and personalized medicine. As well, the review will discuss how stem cell drugs have led to a new direction in stem cell therapy, providing a new platform for patient needs.


2014 ◽  
Vol 9 (1) ◽  
pp. 9-12 ◽  
Author(s):  
Marguerite Ryan Irvin ◽  
Stella Aslibekyan ◽  
Bertha Hidalgo ◽  
Donna K Arnett

Author(s):  
Michael Snyder

What other technologies will be prevalent in the personalized medicine space? The information gathered from genomics will ultimately be coupled with other technologies to further guide and treat human health. For example, it is now possible to construct pluripotent stem cells from any individual....


Author(s):  
John Furia ◽  
Mark Lundeen ◽  
Jason Hurd ◽  
David Pearce ◽  
Christopher Alt ◽  
...  

Recently, the management of musculoskeletal disorders with the patients' own stem cells, isolated from the walls of small blood vessels, which can be found in great numbers in the adipose tissue, has received considerable attention. The use of these autologous, unmodified stem cells can be seamlessly integrated into modern orthopedic treatment concepts, which can be understood as the optimization of a process which - albeit less efficiently - also takes place physiologically. Accordingly, this new safe and effective type of treatment is attractive in terms of holistic thinking and personalized medicine.


Sign in / Sign up

Export Citation Format

Share Document